A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants

References

• Arístegui J, Usonis V, Coovadia H, Riedemann S, Win KM, Gatchalian S, Bock HL. Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 2003; 7(2):143-51; PMID:12839717; https://doi.org/10.1016/S1201-9712(03)90011-7
   PubMedGoogle Scholar
• Li Y, Li RC, Ye Q, Li C, Liu YP, Ma X, Li Y, Zhao H, Chen X, Assudani D, et al. Safety, immunogenicity and persistence of immune response to the combined diphtheria, tetanus, acellular pertussis, poliovirus and Haemophilus influenzae type b conjugate vaccine (DTPa-IPV/Hib) administered in Chinese infants. Hum Vaccines Immunother 2016; 13(3):588-98 (just-accepted):00-
   PubMed Web of Science ®Google Scholar
• Hansen J, Timbol J, Lewis N, Pool V, Decker MD, Greenberg DP, Klein NP. Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine 2016; 34(35):4172-9; PMID:27373595; https://doi.org/10.1016/j.vaccine.2016.06.062
   PubMed Web of Science ®Google Scholar
• Marshall GS, Happe LE, Lunacsek OE, Szymanski MD, Woods CR, Zahn M, Russell A. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J 2007; 26(6):496-500; https://doi.org/10.1097/INF.0b013e31805d7f17
   PubMed Web of Science ®Google Scholar
• Kalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J 2006; 25(6):507-12; https://doi.org/10.1097/01.inf.0000222413.47344.23
   PubMed Web of Science ®Google Scholar
• Mitchell VS, Philipose NM, Sanford JP, editors. The Children's Vaccine Initiative: Planning Alternative Strategies. Washington DC: National Academy Press; 1993, p. 196-203
   Google Scholar
• Dhingra MS, Rao R, Bhat S, Joshi R, Kalra V, Parikh HR, Rao SN, Sethi GR, Shah N, Muzaffaruddin M. Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: A phase III trial. Hum Vaccines 2010; 6(7):572-7; PMID:20421723; https://doi.org/10.4161/hv.6.7.11817
   PubMed Web of Science ®Google Scholar
• Watemberg N, Dagan R, Arbelli Y, Belmaker I, Morag A, Hessel L, Fritzell B, Bajard A, Peyron L. Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. Pediatr Infect Dis J 1991; 10(10):758-63; https://doi.org/10.1097/00006454-199110000-00008
   PubMed Web of Science ®Google Scholar
• Barra A, Dagan R, Preud'homme JL, Bajart A, Danve B, Fritzell B. Characterization of the serum antibody response induced by Haemophilus influenzae type b tetanus protein-conjugate vaccine in infants receiving a DTP-combined vaccine from 2 months of age. Vaccine 1993; 11(10):1003-6; PMID:8212818; https://doi.org/10.1016/0264-410X(93)90124-G
   PubMed Web of Science ®Google Scholar
• Dagan R, Botujansky C, Watemberg N, Arbelli Y, Belmaker I, Ethevenaux C, Fritzell B. Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine. Pediatr Infect Dis J 1994; 13(5):356-62; https://doi.org/10.1097/00006454-199405000-00005
   PubMed Web of Science ®Google Scholar
• Amir J, Melamed R, Bader J, Ethevenaux C, Fritzell B, Cartier JR, Arminjon F, Dagan R. Immunogenicity and safety of a liquid combination of DTP-PRP-T [corrected] vs lyophilized PRP-T reconstituted with DTP. Vaccine 1997; 15(2):149-54; PMID:9066031
   PubMed Web of Science ®Google Scholar
• Kaplan SL, Lauer BA, Ward MA, Wiedermann BL, Boyer KM, Dukes CM, Schaffer DM, Paisley J, Mendelson R, Pedreira F, et al. Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone or mixed with diphtheria-tetanus-pertussis vaccine in infants. J Pediatr 1994; 124(2):323-7; PMID:8301447
   PubMed Web of Science ®Google Scholar
• Sharma H, Yadav S, Patil V, Chacko B, Kapre S, Jadhav S, Ravetkar S, Bahl S, Parekh S, Chakravarty A, et al. A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6–14 weeks. Vaccine 2011; 29(48):8773-9; PMID:21968445
   PubMed Web of Science ®Google Scholar
• Kanra G, Silier T, Yurdakok K, Yavuz T, Baskan S, Ulukol B, Ceyhan M, Ozmert E, Türkay F, Pehlivan T. Immunogenicity study of a combined diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis vaccine used to reconstitute a freeze-dried Haemophilus influenzae type b vaccine (DTaP-IPV//PRP-T) administered simultaneously with a hepatitis B vaccine at two, three and four months of life. Vaccine 1999; 18(9-10):947-54; PMID:10580209
   PubMed Web of Science ®Google Scholar
• Rao R, Dhingra MS, Bavdekar S, Behera N, Daga SR, Dutta AK, Kundu R, Maiya P, Mishra P, Shah R, et al. A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (liq) and TritanrixHB + Hiberix (lyo) in Indian infants administered according to the EPI schedule. Hum Vaccine 2009; 5(6):425-9
   PubMed Web of Science ®Google Scholar
• Scheifele DW. Recent trends in pediatric Haemophilus influenzae type B infections in Canada. Immunization Monitoring Program, Active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease Control. Canadian Med Association J 1996; 154(7):1041-7; PMID:8625025
   PubMed Web of Science ®Google Scholar
• Marcy SM, Kohl KS, Dagan R, Nalin D, Blum M, Jones MC, Hansen J, Labadie J, Lee L, Martin BL, et al. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004; 22(5):551; PMID:14741143
   PubMed Web of Science ®Google Scholar
• Kohl KS, Walop W, Gidudu J, Ball L, Halperin S, Hammer SJ, Heath P, Varricchio F, Rothstein E, Schuind A, et al. Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine 2007; 25(31):5858; PMID:17548132
   PubMed Web of Science ®Google Scholar
• Gidudu JF, Walco GA, Taddio A, Zempsky WT, Halperin SA, Calugar A, Gibbs NA, Hennig R, Jovancevic M, Netterlid E, et al. Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2012; 30(30):4558-77; PMID:22521267
   PubMed Web of Science ®Google Scholar
• Donken R, De Melker H, Rots N, Berbers G, Knol M. Comparing vaccines: A systematic review of the use of the non-inferiority margin in vaccine trials. Vaccine 2015; 33(12):1426-32; PMID:25659273; https://doi.org/10.1016/j.vaccine.2015.01.072
   PubMed Web of Science ®Google Scholar
• Patel MK, Patel TK, Tripathi CB. Diphtheria, pertussis (whooping cough), and tetanus vaccine induced recurrent seizures and acute encephalopathy in a pediatric patient: Possibly due to pertussis fraction. J Pharmacol Pharmacother 2012; 3:71-3
   PubMedGoogle Scholar
• Howson CP, Fineberg HV. Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine. JAMA 1992; 267:392-6
   PubMed Web of Science ®Google Scholar
• Tro-Baumann B, von Spiczak S, Lotte J, Bast T, Haberlandt E, Sassen R, et al. A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome. Epilepsia 2011; 52:175-8
   PubMed Web of Science ®Google Scholar
• McIntosh AM, McMahon J, Dibbens LM, Iona X, Mulley JC, Scheffer IE, Berkovic SF. Effects of vaccination on onset and outcome of Dravet syndrome: A retrospective study. Lancet Neurol 2010; 9:592-8
   PubMed Web of Science ®Google Scholar
• Edwards KM, Decker MD, Mortimer EA Jr. Pertussis Vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. Philadelphia: W.B. Saunders Company; 1999
   Google Scholar
• Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB, Mullooly JP, Thompson RS; Vaccine Safety Datalink Team. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003; 112:815-20
   PubMed Web of Science ®Google Scholar